These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14569207)

  • 1. Evaluation and management of pulmonary hypertension in systemic sclerosis.
    Preston IR; Hill NS
    Curr Opin Rheumatol; 2003 Nov; 15(6):761-5. PubMed ID: 14569207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline pulmonary pressures in scleroderma - a 'pre-pulmonary arterial hypertension' condition?
    Kovacs G; Olschewski H
    Arthritis Res Ther; 2015 May; 17(1):123. PubMed ID: 25981512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians.
    Mangat P; Conron M; Gabbay E; Proudman SM;
    Intern Med J; 2010 Jul; 40(7):494-502. PubMed ID: 19460060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary?
    Foocharoen C; Mahakkanukrauh A; Pussadhamma B; Netwijitpan S; Suwannaroj S; Nanagara R
    J Clin Rheumatol; 2014 Aug; 20(5):268-74. PubMed ID: 25036561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary arterial hypertension in collagen disease: findings of the German Network for Systemic Scleroderma].
    Halank M; Seyfarth HJ; Opitz C; Schmeisser A; Ewert R; Höffken G
    Dtsch Med Wochenschr; 2007 Feb; 132(7):337; author reply 338. PubMed ID: 17286224
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
    Hoeper MM
    Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.
    Moinzadeh P; Riemekasten G; Siegert E; Fierlbeck G; Henes J; Blank N; Melchers I; Mueller-Ladner U; Frerix M; Kreuter A; Tigges C; Lahner N; Susok L; Guenther C; Zeidler G; Pfeiffer C; Worm M; Karrer S; Aberer E; Bretterklieber A; Genth E; Simon JC; Distler JH; Hein R; Schneider M; Seitz CS; Herink C; Steinbrink K; Sárdy M; Varga R; Mensing H; Mensing C; Lehmann P; Neeck G; Fiehn C; Weber M; Goebeler M; Burkhardt H; Buslau M; Ahmadi-Simab K; Himsel A; Juche A; Koetter I; Kuhn A; Sticherling M; Hellmich M; Kuhr K; Krieg T; Ehrchen J; Sunderkoetter C; Hunzelmann N;
    J Rheumatol; 2016 Jan; 43(1):66-74. PubMed ID: 26568599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.
    Mullin CJ; Mathai SC
    Curr Opin Rheumatol; 2017 Nov; 29(6):561-567. PubMed ID: 28817465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.
    Attanasio U; Cuomo A; Pirozzi F; Loffredo S; Abete P; Petretta M; Marone G; Bonaduce D; De Paulis A; Rossi FW; Tocchetti CG; Mercurio V
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?
    Nikpour M; Stevens W; Proudman SM; Buchbinder R; Prior D; Zochling J; Williams T; Gabbay E; Nandurkar H
    Intern Med J; 2013 May; 43(5):599-603. PubMed ID: 23668273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension: an autoimmune disease?
    Mouthon L; Guillevin L; Humbert M
    Eur Respir J; 2005 Dec; 26(6):986-8. PubMed ID: 16319325
    [No Abstract]   [Full Text] [Related]  

  • 13. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study.
    Riccieri V; Vasile M; Iannace N; Stefanantoni K; Sciarra I; Vizza CD; Badagliacca R; Poscia R; Papa S; Mezzapesa M; Nocioni M; Valesini G
    Rheumatology (Oxford); 2013 Aug; 52(8):1525-8. PubMed ID: 23671125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].
    Volkov AV; Kurmukov IA; Yudkina NN; Glukhova SI; Nikolaeva EV
    Ter Arkh; 2015; 87(1):49-56. PubMed ID: 25823269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients.
    Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.
    Hamaguchi Y; Fujimoto M; Hasegawa M; Matsushita T; Takehara K
    J Dermatol Sci; 2009 Jul; 55(1):66-7. PubMed ID: 19342201
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension.
    Bargagli E; Galeazzi M; Bellisai F; Volterrani L; Rottoli P
    Respiration; 2008; 75(3):346-9. PubMed ID: 16369127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary arterial hypertension in collagenoses: clinical features, epidemiology, pathogenesis, diagnosis and treatment].
    Ahmadi-Simab K; Gross WL
    Z Rheumatol; 2006 Jul; 65(4):297-300, 302-5. PubMed ID: 16804698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition?
    Black C
    Rheumatology (Oxford); 2005 Feb; 44(2):141-2. PubMed ID: 15681336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.